Weill Cornell

New York, NY

Sorting 2 by

Accepting patients

Safety Study of Cord Blood Units

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
Learn more
  • Allogeneic Stem Cell Transplant
  • Phase 2

Not currently accepting

Luspatercept and Lenalidomide (L2)

A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
Learn more
  • Immunomodulatory Drug
  • Red Blood Cell Stimulant
  • Erythroid Maturation Agent (EMA)
  • Phase 1/2